137 related articles for article (PubMed ID: 19536853)
1. Brachytherapy boost for T1/T2 nasopharyngeal carcinoma.
Yeo R; Fong KW; Hee SW; Chua ET; Tan T; Wee J
Head Neck; 2009 Dec; 31(12):1610-8. PubMed ID: 19536853
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma{private}.
Leung TW; Wong VY; Sze WK; Lui CM; Tung SY
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):361-7. PubMed ID: 17892917
[TBL] [Abstract][Full Text] [Related]
4. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma.
Yau TK; Sze WM; Lee WM; Yeung MW; Leung KC; Hung WM; Chan WI
Head Neck; 2004 Dec; 26(12):1024-30. PubMed ID: 15390194
[TBL] [Abstract][Full Text] [Related]
6. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
7. Treatment results of 59 young patients with nasopharyngeal carcinoma.
Selek U; Ozyar E; Ozyigit G; Varan A; Buyukpamukcu M; Atahan IL
Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
[TBL] [Abstract][Full Text] [Related]
8. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.
Yu KH; Leung SF; Tung SY; Zee B; Chua DT; Sze WM; Law SC; Kam MK; Leung TW; Sham JS; Lee AW; Au JS; Hui EP; Sze WK; Cheng AC; Yau TK; Ngan RK; Wong FC; Au GK; Chan AT;
Head Neck; 2005 May; 27(5):397-405. PubMed ID: 15726589
[TBL] [Abstract][Full Text] [Related]
9. Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution.
Yi JL; Gao L; Huang XD; Li SY; Luo JW; Cai WM; Xiao JP; Xu GZ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):161-8. PubMed ID: 16542792
[TBL] [Abstract][Full Text] [Related]
10. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma.
Hara W; Loo BW; Goffinet DR; Chang SD; Adler JR; Pinto HA; Fee WE; Kaplan MJ; Fischbein NJ; Le QT
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):393-400. PubMed ID: 18164839
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
[TBL] [Abstract][Full Text] [Related]
12. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
Fusco V; Troiano M; Corsa P; Raguso A; Lioce M; Lauriola P; Parisi S
Radiol Med; 1998 Jun; 95(6):640-6. PubMed ID: 9717549
[TBL] [Abstract][Full Text] [Related]
13. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome with low-dose-rate interstitial brachytherapy in early-stage oral tongue cancers.
Bhalavat RI; Mahantshetty UM; Tole S; Jamema SV
J Cancer Res Ther; 2009; 5(3):192-7. PubMed ID: 19841561
[TBL] [Abstract][Full Text] [Related]
15. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT
Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829
[TBL] [Abstract][Full Text] [Related]
16. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma.
Takácsi-Nagy Z; Polgár C; Oberna F; Somogyi A; Major T; Remenár E; Fodor J; Kásler M; Németh G
Strahlenther Onkol; 2004 Dec; 180(12):768-75. PubMed ID: 15592696
[TBL] [Abstract][Full Text] [Related]
17. Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease.
Leung TW; Tung SY; Wong VY; Sze WK; Lui CM; Wong FC; Lee AS; O SK
Cancer; 2005 Oct; 104(8):1648-55. PubMed ID: 16118806
[TBL] [Abstract][Full Text] [Related]
18. External beam radiotherapy with endocavitary boost for nasopharyngeal cancer: treatment results and late toxicity after extended follow-up.
Schinagl DA; Marres HA; Kappelle AC; Merkx MA; Pop LA; Verstappen SM; Kaanders JH
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):689-95. PubMed ID: 20231060
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of three-dimensional conformal radiotherapy for treating early primary nasopharyngeal carcinoma.
Luo W; Ye L; Yu Z; He Z; Li F; Liu M
Am J Clin Oncol; 2010 Dec; 33(6):604-8. PubMed ID: 20051809
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional conformal radiotherapy versus intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma.
Zheng XK; Chen LH; Chen YQ; Deng XG
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):165-70. PubMed ID: 15337552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]